ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi GCVRZ

Sanofi GCVRZ listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi GCVRZ

Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 crore from Indian pharma giants
Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has been reduced to ₹2,000 crore due to declining sales and g
Announcement as on 15 April 2025

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple sclerosis.
Announcement as on 25 March 2025

Sanofi launches Rezurock against chronic Graft-versus-host disease in India
Sanofi Healthcare India has obtained marketing authorization for Rezurock, a drug for treating Chronic graft versus host disease (cGVHD), a condition that occurs after allogeneic stem cell transplants. The drug, approved by USFDA and CDSCO, offers a new tr
Announcement as on 10 February 2025

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?
Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement as on 18 December 2024

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?
Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement as on 18 December 2024

Announcements by Sanofi first page | Next page | Prev page |

GCVRZ Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 0.87
  • 12Day Average: 0.87
  • 20Day Average: 0.87
  • 50Day Average: 0.87
  • 100Day Average: 0.83
  • 150Day Average: 0.73
  • 200Day Average: 0.68

GCVRZ Indicators & signals

Indicator MACD (12,26,9)

0.84, 0.81, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 28.57, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GCVRZ Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Mar 2020 0.87 0.87 to 0.88 0% 18.75 times
02 Mon Mar 2020 0.87 0.87 to 0.87 0% 0.55 times
28 Fri Feb 2020 0.87 0.87 to 0.88 0% 1.5 times
27 Thu Feb 2020 0.87 0.87 to 0.88 0% 5.49 times
26 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.2 times
25 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.24 times
24 Mon Feb 2020 0.87 0.86 to 0.87 0% 0.57 times
21 Fri Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
20 Thu Feb 2020 0.87 0.87 to 0.87 0% 0.09 times
19 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.28 times
18 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
17 Mon Feb 2020 0.87 0.87 to 0.87 0% 0 times

Videos related to: GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top